Skip to main content
Screener/Healthcare/Biotechnology

KNSA — Kiniksa Pharmaceuticals, Ltd.

NASDAQ
$58.59+1.66 (+2.92%)
Mid CapHealthcareFastest GrowingLow Beta
$24.85
$58.85
$56.83
$58.85
EPS (TTM)$0.91
P/E Ratio64.38
Dividend Yield—
Market Cap$4.10B
Volume260K
Prev Close$56.93
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$214.3M$22.6M$0.270.0%10.5%
Q4 '25$202.1M$14.2M$0.1854.9%7.0%
Q3 '25$180.9M$18.4M$0.2353.8%10.2%
Q2 '25$156.8M$17.8M$0.2354.7%11.4%
Q1 '25$137.8M$8.5M$0.1155.3%6.2%
Q4 '24$122.5M-$8.9M$-0.1246.0%-7.3%
Q3 '24$112.2M-$12.7M$-0.1856.0%-11.3%
Q2 '24$108.6M-$3.9M$-0.0660.9%-3.6%
Get Your Daily Market Recap